Related Experiment Video

Updated: Jun 8, 2026

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

[VEGF antibodies as therapy for retinopathy of prematurity]

I M Oberacher-Velten1, H Helbig

  • 1Klinik und Poliklinik für Augenheilkunde, Klinikum der Universität Regensburg. isabel.velten@klinik.uniregensburg.de

Klinische Monatsblatter Fur Augenheilkunde
|September 17, 2010
PubMed

Insights

Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. New therapies using vascular endothelial growth factor antibodies offer a less destructive approach to treating ROP and preventing vision loss.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Vascular Biology

Context:

  • Retinopathy of prematurity (ROP) is a significant cause of childhood legal blindness.
  • Advances in neonatal care increase survival rates of premature infants, elevating ROP risk.
  • Current laser therapy for ROP is destructive, causing retinal damage without improving development.

Purpose:

  • To report experience with vascular endothelial growth factor (VEGF) antibodies as a novel therapy for ROP.
  • To provide an overview of current literature on VEGF antibody treatment for ROP.
  • To evaluate the efficacy and safety of VEGF antibodies in managing ROP.

Summary:

  • This article details the use of VEGF antibodies, a new therapeutic strategy for ROP.
  • It presents the authors' clinical experience with this innovative treatment.
  • The study reviews existing literature on VEGF antibodies for ROP management.

Impact:

  • VEGF antibody therapy represents a potentially less destructive alternative to laser photocoagulation for ROP.
  • This approach may preserve retinal development while preventing blindness.
  • It offers a promising new avenue for improving visual outcomes in premature infants.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
The Retina01:32

The Retina

The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.